After PD-1 binds to its ligands PD-L1 or PD-L2 in tumor cells and tumor microenvironment, it transmits inhibitory signals to T effector cells, hinders T cell survival, and facilitates immune tolerance (96, 97). The gene discussed is PDCD1LG2; the disease is neoplasm.